Dopl's platform is hardware-agnostic, integrating off-the-shelf robots, ultrasound systems, haptic controllers, and cameras so it can deploy rapidly across existing hospital infrastructure rather than requiring proprietary hardware.
It has completed FDA pre-submission engagement on a 510(k) regulatory pathway with patented technology, and its existing CareBridge service gives it direct clinical traction with critical access hospitals ahead of clearance.
Dopl targets more than 50 million missed ultrasound exams each year in the United States alone, estimating a $40 billion annual reimbursement opportunity for hospitals as telerobotic imaging scales nationally.
Rural and workforce-constrained regions, where imaging expertise is unevenly distributed and patients often travel hours for care, are the primary market the company is built to serve.
Dopl's product ecosystem is a telerobotic ultrasound platform centered on Traverse, a remote robotic ultrasound system, paired with Dopl Connect for secure connectivity and SonoFlex for distributed clinical workforce management.
While pursuing FDA clearance the company operates CareBridge, an in-person ultrasound coverage service deploying traveling sonographers to critical access hospitals, which has cut patient wait times by up to 90 percent.
